Recent Quotes (30 days)

You have no recent quotes
chg | %

Transgene Biotek Ltd  

(Public, BOM:526139)   Watch this stock  
Find more results for BOM: 526139
+0.04 (1.61%)
Jan 19 - Close
BOM real-time data - Disclaimer
Currency in INR
Range 2.37 - 2.56
52 week 1.69 - 3.49
Open 2.49
Vol. 29,559.00
Mkt cap 191.70M
P/E 1.43
Div/yield     -
EPS 1.76
Shares 75.77M
Beta     -
Inst. own     -

Key stats and ratios

Q1 (Mar '12) 2017
Net profit margin -260.10% -7006.78%
Operating margin -16.69% -7152.72%
EBITD margin - -911.91%
Return on average assets -14.74% -7.70%
Return on average equity -17.04% -16.86%
CDP Score - -


C-44, Madhuranagar, S R Nagar
MEDAK, 502325
+91-40-65589499 (Phone)
+91-8458-279755 (Fax)

Website links


Transgene Biotek Limited is an India-based biotechnology company. The Company operates transgene medical centers. The Company's segments include Diagnostic Services, CRO Services and API-DHA. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. Its oncology products include TBL-0404, used for the treatment of metastatic liver cancer; TBL-0905, used for the treatment of metastatic breast cancer, and TBL-0306C, used for the treatment of colon cancer. Its auto-immunity products include TBL-1203HI, used for the treatment of human immunodeficiency virus (HIV), and TBL-1108MS, used for the treatment of multiple sclerosis. Its drug delivery products include TBL-1002OI, used for the treatment of oral delivery of insulin, and TBL-1004HI, used for the treatment of oral delivery of HIV drug. The Company's biogenerics products include Tacrolimus, Orlistat and docosahexaenoic acid (DHA).

Officers and directors

K. Koteswara Rao Chairman of the Board, Compliance Officer, Managing Director
Shyam Shankar Das Director
Age: 46
Sarang Subhash Puranik Director
Age: 35
P. K. Ghosh Independent Director
Soma Sekhar Marthi Independent Director
L. Sujana Independent Director